Search for: "United States v. Cartwright" Results 21 - 40 of 45
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Aug 2008, 6:30 am
LEXIS 57423 (WD WI, July 22, 2008), a Wisconsin federal district court permitted a Muslim inmate to proceed with claims that he was denied access to Muslim religious services and to Halal food.In Cartwright v. [read post]
20 Aug 2008, 10:39 pm
 Andersen announced in June 2002 that it would cease its accounting practices in the United States. [read post]
21 Mar 2007, 5:10 am
Because we focus here on the cy près distribution of unclaimed settlement proceeds, we note only that following a 1999 federal court trial of state and federal antitrust actions, the district court found against Microsoft, see United States v. [read post]
4 Nov 2009, 11:39 am
Cartwright J. [read post]
6 Mar 2009, 7:03 am
"[i]Watson was filed in the United States District Court for the Central District of California and alleges violations of Sections 1 and 2 of the Sherman Act, Section 5(a) of the FTC Act, and California's Cartwright and Unfair Competition Acts. [read post]
20 Aug 2013, 5:00 am by Kimberly A. Kralowec
Supreme Court Order (01/11/12): In light of the United States Supreme Court's order vacating our judgment in the above-entitled case and remanding the cause to this court "for further consideration in light of AT&T Mobility LLC. v. [read post]
20 Apr 2015, 6:30 am
Yücel is a citizen of Sweden . . ., and was extradited from the Republic of Moldova to the United States in May 2014.U.S. v. [read post]
13 Mar 2014, 12:22 pm by Brenda Fulmer
Under current law, as confirmed by the United States Supreme Court in the Pliva v. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
Interestingly, Plaintiffs assume that Ranbaxy maintains 180-day exclusivity eligibility for generic NEXIUM; however, as we previously noted there has been speculation that Ranbaxy’s ANDA for generic NEXIUM Delayed-release Capsules is one of the unidentified ANDAs in the Consent Decree the United States filed against Ranbaxy earlier this year and for which Ranbaxy agreed to forfeit 180-day exclusivity.  [read post]